"The question is does the FDA need to see a condition ‘cured’ or can the prevention of an adverse physiological reaction be sufficient for approval for use, like paracetamol."
It is a good question GC but also remember that "cures" are very hard to come by a large amount of drugs don't "cure" diseases as there are many that are incurable at this point alot of the current drugs for those diseases are about improving QAL, slowing progression &/or managing it. I'd assume & it is only my assumption but NNZ-2566 would only need to show an improvement in the above greater than anything currently available for it to be approved.
nnz-2556 multi-acting medicine, page-2
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.30 |
Change
-0.090(0.46%) |
Mkt cap ! $2.443B | |||
| Open | High | Low | Value | Volume |
| $19.55 | $19.65 | $18.88 | $10.53M | 549.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 4552 | $19.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.30 | 674 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |